entertainment -WSS

entertainment

author：focus 2025-10-01 23:00:52 - browse：8417

Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed. Joe Raedle/Getty Images

Walmart seems poised to increase its health care footprint by buying value-based senior care company ChenMed, per reports from Bloomberg.

Experts largely hailed the rumored sale as a good buy, citing the management of chronic conditions in the Medicare Advantage population through primary care, ChenMed’s specialty, as an area with huge innovation and cost savings over the last 10 years.

“If you’re going to purchase primary care in the senior space, there’s no one better than ChenMed. The only other one that might be better or equivalent would be Oak Street, but they were just purchased,” said Jon Kaplan, a senior partner at BCG. “In the world of great primary care practices to buy, in my top two are Oak Street and ChenMed, and one of them’s available, one’s not.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Life sciences investors close nearly $6 billion in new funds

entertainment

WSS

Anthony Fauci pushes back on GOP claims during Covid hearing

Life sciences investors close nearly $6 billion in new funds

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

STAT wants to know your pick for a great summer read or listen

Fight over Supreme Court dialysis ruling puts kidney patients at risk

CMS got Medicare Advantage quality rating wrong, judge rules

entertainment

entertainment

hotspot

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Activists slam private health insurers over coverage restrictions

Kidney transplant patients stopped immunosuppressants in trial

Psychedelics group wrestles with new pharma identity

Stopping antidepressants leads to symptoms for 1 in 6 patients

Walensky prepares to leave CDC — and Congress — behind

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stopping antidepressants leads to symptoms for 1 in 6 patients

hotspot

Readout LOUD podcast: ESMO highlights & Roivant's big deal

FDA approves Moderna’s RSV vaccine, its second licensed product

Data don't support strong claims for Covid

Medicare must police algorithms in Medicare Advantage, Dems say

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

entertainment

leisure time

explore

Wikipedia